Ivermectin Treatment Efficacy in Covid-19 High Risk Patients
NCT04920942
·
clinicaltrials.gov ↗
PHASE3
Phase
COMPLETED
Status
500
Enrollment
OTHER
Sponsor class
Conditions
COVID-19
Interventions
DRUG:
Ivermectin 0.4mg/kg/day for 5 days
Sponsor
Clinical Research Centre, Malaysia